M&A

Roche Open to Small, Medium-Sized Deals, SonntagsZeitung Says
Bloomberg
Sun, 11/21/10 - 01:39 pm
Roche
M&A
AstraZeneca leaves door open for sale of Swedish unit Astra Tech, which analysts value at $2B
Yahoo/AP
Fri, 11/19/10 - 11:15 am
AstraZeneca
M&A
Astra Tech
dental implants
Moody's repeats gloomy view of pharma industry
Fierce Pharma
Thu, 11/18/10 - 10:59 am
pharma industry
M&A
Roche
Novartis
Genzyme Wait for Higher Bid Risky Due to FDA Plant Deadline, Orbimed Says
Bloomberg
Thu, 11/18/10 - 09:39 am
M&A
Genzyme
Sanofi
Sekisui to Buy Genzyme’s Test-Drug Operations For $265 Million
Bloomberg
Thu, 11/18/10 - 08:00 am
Genzyme
M&A
Sekisui
Actelion, Eyed by Amgen, May Fetch $9.8 Billion in Takeover, Analysts Say
Bloomberg
Thu, 11/18/10 - 07:58 am
Actelion
Amgen
M&A
Actelion shares surge (again) as M&A buzz hits fever pitch
Fierce Biotech
Wed, 11/17/10 - 11:46 am
Actelion
M&A
Amgen
Drugmaker's Acquisitions to Weigh on Credit Ratings, Moody's Analysts Say
Bloomberg
Wed, 11/17/10 - 11:44 am
M&A
credit rating
Pfizer
King
Crucell
JNJ
Novartis closes in on growth formula
FT.com
Mon, 11/15/10 - 08:51 pm
Novartis
M&A
Alcon
No White Knight for Genzyme
Minyanville
Mon, 11/15/10 - 06:25 pm
Sanofi
Takeda
Genzyme
M&A
Genzyme in Talks to Sell Itself to Japan’s Takeda, Mail Says
Bloomberg
Mon, 11/15/10 - 10:39 am
Takeda
Genzyme
M&A
UCB Falls Most in Six Months as UBS Downgrades, Says Takeover Is Unlikely
Bloomberg
Mon, 11/15/10 - 10:38 am
UCB Pharmaceuticals
M&A
Cimzia
Pfizer
rheumatoid arthritis
Human Genome May Be Takeover Target If U.S. Approves Lupus Drug Benlysta
Bloomberg
Thu, 11/11/10 - 06:39 pm
lupus
Human Genome Sciences
M&A
Benlysta
Expect more megamergers, GSK exec says
Fierce Pharma
Wed, 11/10/10 - 11:41 am
M&A
GSK
Genzyme Still Open To Sweeter Sanofi Bid
Forbes
Tue, 11/9/10 - 04:07 pm
Sanofi
Genzyme
M&A
What Genzyme’s CEO Doesn’t Know, and Doesn’t Want to Know, About Sanofi’s Hostile Bid
BNET Pharma
Mon, 11/8/10 - 03:44 pm
Henri Termeer
Sanofi
Genzyme
M&A
Sanofi Asks Genzyme to Keep Deal Path Open
NY Times, NY
Mon, 11/8/10 - 03:42 pm
Genzyme
Sanofi
M&A
Vivus sells Muse assets for $23.5M
Bizjournals.com
Mon, 11/8/10 - 10:51 am
M&A
Muse
Vivus
Meda
erectile dysfunction
Eli Lilly to buy Avid Radiopharmaceuticals
Marketwatch
Mon, 11/8/10 - 09:40 am
Avid
Eli Lilly
M&A
Merit Medical Announces Results for the Quarter Ended September 30, 2010 and Gives Update on Recent Acquisitions
Fri, 11/5/10 - 09:16 am
Merit Medical Systems
M&A

Pages